Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

750 Views

Favorite
Facebook
Tweet
Print

Session: In the Era of Shorter Is Better, Does the Data Apply to My Immunocompromised/Transplant Patient? A Critical Review of the Evidence

250 - Duration of treatment of Gram-negative bacteremia in immunocompromised patients

Friday, October 18, 2024

8:00 AM – 8:30 AM US PT

Location: 403 B

Speaker(s)

David van Duin, MD, PhD

Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States

Slides

Disclosure(s):

David van Duin, MD, PhD: Merck: Advisor/Consultant (), Grant/Research Support (); Pfizer: Advisor/Consultant (); Qpex: Advisor/Consultant (); Roche: Advisor/Consultant (); Shionogi: Advisor/Consultant (), Grant/Research Support ()